STATISTICS IN MEDICINI Statist. Med. 2000, 19: 3523-3526 AUTHOR INDEX Abate, J. F., 99 Bonetti, M., 2595 D’ Agostino, R. B. Sr, 763, 1495 Abrams, K. R., 3359 Borgdorff, M., 1849 Dannegger, F., 475, 601 Abramson, I. S., 1421 Bouckaert, A., 239 Davidov, O., 1983 Agresti, A., 1115, 177 Boyett, J.M ., 205 Dean, C. B., 2421 Akazawa, K., 195 5 Boyle, D., 2811 Deguen, S., 1207 Akhtar-Danesh, N Brender, J. D., 1081 DeKosky, S I . 1453 Allen-Mersh, T. ¢ Brittenham, G. M., 83 Delgado-Rodriguez, M., 1089 Altman,D . G., 453, 32 Brock, D., 1577 Diamond, M. R., 1295 Ambrosius, W. T., 1339 Broemeling, L. D., 957 Dickinson, H. O., 849 Andersen, P. K., 587 Brookmeyer, R., 1481 Dietz, E., 2333 Anderson, S., 887 Broom, B. M., 1217 Diggle, P., 849 Appleton, D. R., 1889 Brown, J., 3389 Ding, L., 1363 Arends, L. R., 3497 Brunner, D., 3345 Divino, F., 2217 Armitage, P., 3165 Byers, S., 2243 Do, K.-A., 1217 Armstrong, P. W., 2037 Dominik, R., 71 Arnold, A., 1411 ai, J., 2963 Donner, A., 373 Aryan, M., 1401 irdon, L. R., 369 Doornbos, G., 2569 Ashby, D., 3291 arlin, B. P., 2265, 2279 Dubray, B., 1237 Auranen, K., 281 arpenter, J., 1141 Duffy, D. L., 1217 arr, D. A., 2521 Duh, S.-H., 99 Bainbridge, J., 3389 ur, D. B., 2521 Dunson, D. B., 665 Baltzan, M., 1901 Castillo-Chavez, C., 82 Dyba, T., 1741 Barber, J. A., 3219 atellier, D. J., 1101 Baron, A. E.. 1969 ge, Y.-C., 1277 Eberly, L. E., 2279 837 Bartfay, I 3 Eckhardt, L., 2933 Baur. M. P.. 3337 vaturvedi, N., 861 Edland, S. D., 1441, 16 Bebchuk, J. D., 405 Chau, N. P., 1207 Edwardes, M. D. deB., 715 3ecker, N. G., 1165 hen, C. W. S., 3095 1901 Beckett, I 4.. 681, 1469 hen. J. J.. 2089 gea, J. M., 2641 Bedrick, E. J., 221 hen, M.-L., 2821 ijkemans, M. J. C., 141, 1059 3ege, C. B., 1997 hen, P.-L., 71 lliot, P., 2493 Beiser, A., 1495 hen, Y.-I 353 Iston, R. C., 369 Bell, B. S., 957 hevret, S., 837 mir, B., 511 Bellocco, R., 297 hinchilli, V. M., 2855 msley, C. L., 1523 Benach, J., 2409 Chinn, S., 3127 ndrenyi, L., 2867 Berg, J. D., 1433 hong, M. Y., 743 ngels, E. A., 1707 Berger, V. W., 1303, 1319 how, S.-C., 1029, 2741 sbjerg S.. 587 Bernardinelli, L., 2493 hristensen, R., 22 scolano, S., 3405 Bernardo, M. V. P., 3023 hristiansen, O. B., 2147 vans, D. A., 1453 Bernsen, R., 1849 lark, a 2217 vans, S. J. W., 3199 Berridge, D. M., 3377 lark, L. C., 1303 Besag, J., 2243 ohen, A., 2699 iraggi, D., 61 Best, N. G., 2493 ole, D. E. C., 743 aries, D. E., 2169 Betensky. R. A., 405 ole, T. J., 3109 ay, M. P., 335 Biggeri, A., 2217, 2539 ook, J. R., 2989 ayers, P. M., 265 Biggerstaff, B. J., 649 ook, N. R., 2625 eldman, U., 575 Binks, K., 849 ooke, G. E., 923 eng, J., 2169 Birch, J. B., 389 orcorcan, C., 3037 euer, E. J., 335, 17 Bithell, J., 1141, 2203 raddock, C., 3005 Fidler, V., 1849 Blackman, N. J.-M., 7 ramer, L. D., 1997 Flynn, E. V., 3325 Blettner, M., 3345 ressie, N 232 779 Forand, S. P., 2399 Boehning, D., 2217 ronin, K. A., 1729 Formann, A. K., 1881 Bohning, D., 2333 ronin-Stubbs, D., 1453 Foster, N. L., 1531 Bolland, K., 2899 ui, J., 1165 Friede, T., 901 3524 AUTHOR INDEX Galasko, D. R., 1421 Hogjbjerre, M., 2147 Lee, K. L., 141 Gao, S., 1523, 1545, 1567, 2101 Holder, D. J., 2885 Lee, S.-M., 3095 Garner, P., 3325 Horton, R., 3149 Lee, Y. J., 1329 Gelb, D. J., 1393 Horvath, S., 3337 Leporrier, M., 837 Gelber, R. D., 2595 Hsiao, C. K., 1915 Leroux, B. G., 2321 Gelfand, A. E., 1865 Hsieh, Y.-H., 3095 Lertprapai, S., 1931 Gelman, A., 2309 Hsuan, F., 2879, 2885 Lesaffre, E., 2217 Geskus, R. B., 1753 Hu, F., 2067 Leyland, A. H., 2469 Gigli, A., 175 Hughes, M. D., 3171 Li, X., 83 Gilbert, P. B., 3065 Hui, S. L., 1339, 1545, 1567, Gill, P. S., 975 2101 Gillman, M. W., 2625 Hundborg, H. H., 2147 Girling, D. J., 2657 Hung, H. M. J., 2079 Giudici, P., 2579 Hutton, J. L., 3325 5, ' Glassman, J. R., 113 Hyneck, M., 2811 Lipton,R . B., 1555 Glasziou, P., 1295 Hyslop, T., 887, 2821, 2885 Littell, R. C., 1793 Goldman, D. A., 1081 Hyténen, M., 1179 Attle, R. J. A., 153 Goldman, J. M., 3005 ju, A., 205 Goldschmidt-Clermont, P. J., Ibrahim, J. G., 3023 ju, H., 2409 923 Izmirlian, G., 1577 iu, X., 1593 Goldstein, H., 2469, 3417 Jorca, J., 1089 Golmard, J.-L., 3465 Jensen, K., 493 ouis, T. A., 2295 Gombosi, f 1531] Johnson, W. O., 221 ubin, J. H., 2185 Gomez, G., 2641 Jones, D. R., 3359 ubsen, J., 3497 Gould, A. L., 2721 Jung, S.-H., 511 ui, K.-J., 2919, 2933 Gould, R. L., 1421 Lukaski, H. C., 83 Graham, P., 937 Kambour, E. L., 83 Luz Calle, M., 2641 Gray, S., 1481 Kang, S.-H., 2089 Grobbee, D. f 3497 Kastner, C., 3345 McCulloch, C. E., 1303 Guggenmoos-Holzmann, L., Kelly, C., 2919 McElvenny, D., 3389 1783 Kelly, P. J., 13 McLachlan, G. J., 83 Guihenneuc-Jouyaux, C., 45 Kieser, M., 901 McLaren, C. E., 83 Kim, H., 2015 McLaren, G. D., 83 Habbema, J. D.) F., 141, 1059 Kim, H.-J., 335 MacNab, Y. C., 2421 Hahn,S ., 332 Ss Kimanani, E. K., 2775, 2797 Maestri, R., 3087 Hakulinen, T., 1741 Kinukawa, N., 1955 Magder, L. S., 99 Haley, V. B., 2399 Kittner, S. J., 99 Mallet, A., 3465 Hall, C. B., 1555 Klar, N., 373 March, J., 697 Hall, K. S., 1523, 1645, 2101 Klein, J. P., 3005 Marchi, M., 2539 Hamilton, D. C., 743 Kleinman, M., 1651 Mariotto, A. B., 161 Hanley, J. A., 313, 715 Klinger, A., 601 Marrett, L. D., 2437 Harrell, F. E. Jr, 1059 Knorr-Held, I Marschner, I. C., 297 Hartel, G., 1295 2579 Marshall, G., 1969 Hartzel, J.. 1115 Koch,G . G., 781, 1039 Martin, N. G., 1217 Hauck, W. W., 887, 2821 Korinek, A.-M., 3465 Martus, P., 525 Hauptmann, M., 2185 Koval, J. J., 723, 1685 Martuzzi, M., 2539 Hauschke, D., 2769 Kreienbrock, L., 2185 Mason, S., 3389 Hazes, M. H., 3433 Kryscio, R. J., 1463, 1607 Mauger, D. T., 2855 He,Z ., 2015 Kuhnert, P., 1217 Mayer, J. A., 2933 Heisterkamp, S. H., 2569 Kulkarni, P. M., 2975 Mazumdar, M., 113 Henderson, R., 563 Kulldorff, M., 2399 Mazza, A., 3087 Hendrie, H. C., 1523, 1645, Mehrotra, D. V., 811 2101 Lagazio, C., 2539 Mehrotra, K. G., 2975 Hennekens, C. H., 2625 Langford, I. H., 2469 Mehta, C., 3037 Hernandez-Suarez, C. M., 827 Lasserre, V., 45 Mendiondo, M. S., 1607 Heyse J ij , 2989 Lau, J., 1707 Michalek, J. E., 2975 Higgs, R. E., 1697 Lauritzen, S. L., 2147 Midthune, D. N., 335 Hilden, J., 431 Lavigne, J., 2775 Miller, J. P., 1463 Hill, E. G., 1363 Lawmepol, A., 1931 Millikan, R. E., 1011 Hilton, J. F., 989 Lawson, A. B., 2217, 2361, Milliken, J. K., 1617 Ho, H.-T., 1029 2451 Moeschberger, M. L., 923 Hoes, A. W., 3497 Le, N. D., 2437 Mohs, R. C., 1401 AUTHOR INDEX Morris, J. ¢ Rosai, J Svensson, 3483 Morton-Jones Rosenberg, P., 2185 Szydlo, R. M.. 3005 Mosseri, V Rosenberger, W. I Moyé, | Rosner, B. A., 2625 aback, N., 2867 Muga, R., 2 Royston, P ilbot, T. O., 2399 Miller, H 2053, 2943 amura, R. N., 2169 Muller Ruberg, S. J., 913 ancredi, D. J., 681 Munga ingen, C. M., 1039 Munk Sackrowitz. H. B... 2699 angenti, A., 3087 Musi Sackrowitz, M., 2699 ango, T 19] Sala, | 1179 aylor, J. M. G., 123 Salmon, D. P., 1421 iylor, J. O., 262 Sambrrok. R 2657 eboe, ( 153 Sanarico.M.. 308 eresi. J. A Sano, M., 1433 errin, N., 17 Santos. I hal, L., | hall, P. f Thomas, G Thomas, R Thomas, R. G Thompson, S. G , <1 I I hmid I itt I ( 44 I rmann, D. J I ripatni cher, M., 4 I sutakawa I urnbull, B. W I urner, D., 2437 I urner, R. M is, S. I I zen [.-¥ er Ba Van der Twee in Duis in Houwelir 340) | in Houwelin Van Noord, P *nkatraman 3526 AUTHOR INDEX Wellek, S., 2755 Witte, J. S., 369 Wellmann, J., 2185 Wolf, P. A., 1495 Wesson Ashford 1607 Wong, E., 71 Zariffa, N. M.-D., 2 White, L., 1577 Wong, W. K., 639 Zelen, M., 1983 Whitehead Wright, E. M., 2943 Zheng, B., 1265, 177 Wieand, S Zhou, X.-H., 1697 lliams, I R., 24 Xiong, X., 205 Zhu, L., 2265 illiams Pickle 225 Xu, R., 3309 Zhu, W., 639 lliams, R., 282 Zhuang, D., 1237 Williamson, P. R 325 Yang, H., 313 Ziegler, A., 3345 Windeler, J., 425 Yang,M ., 3417 Zwinderman, A. H., 3433 Winget, M., 2409 Yasui, Y., 2409 STATISTICS IN MEDICINE Statist. Med. 2000: 19. 3527 SUBJECT INDEX* Author and subject indexes BN3 2D], UK SUBJECT INDEX antedependence test, post-operative pain, 1889 barrier methods, transitional model, 71 antidepressant clinical trials, time to onset of baseline hazards, Cox-based recurrent event model response 2169 13 ipproximate Bayesian bootstrap (ABB), interval baseline measurement role. 86] censored data, |! baseline risk area under the curve meta-analysis 3497 bioequivalence, 2769, 2811, 2821, 2843, 2855 non-compliance and sample ize, 2689 individual bioequivalence, 2775 Bayes theorem messy longitudinal data, 2657 scoring systems, 575 post-operative pain, 1889 sensitivity and specificity, 1783 rea under ROC curve space-time mixture modelling, 2333 o receiver operating characteristic (ROC Bayesian bootstrap, approximate, | Bayesian decision-making, evidence-based medi liagnostic markers effectiveness, 2 329] prognostic modelling, 1059 Bayesian graphical models, foetal loss familial tumour staging and grading systems, 1997 tendency 1A7j ireal data, disease mapping, 2203 Bayesian hierarchic al models irtificial neural networks, prognostic and diagnostic disease mapping, 2493 2439 lassification, 541 generalized synthesis of evidence, 3359 Aspirin Myocardial Infarction Study (AMIS), 2919 longitudinal biomarkers, 61 association studies, statistical genetics, 333 spatio-temporal interaction O151 asthma Bayesian hierarchical spatial model, probabilistic Saaion spatial model selection 1915 small area risk assessment 345 spatio-temporally misaligned data 2265 Bayesian information criterion BIC symmetric sigmoid curves, monotonic non linear cluster modelling, 2361 model 194 053 interval censored data, 26 isymptotic test, non-inferiority, 2089 Bayesian intensity model, : asymptotic trend test, power comparisons, 3037 back-calculation, 28 ittributable risk confidence intervals, 1089 Bayesian methods auto-Poisson model, disease mapping, 2539 accelerated failure time jutocorrelated errors, joinpoint regression, 335 Alzheimer’s disease sutocorrelation, robust mi xed linear model, 975 disease mapping, 957 ' autoregressive Covariance structure, covariance struc disease prev alence, 68 ture modelling, 1793 false positive ¢ umulative risk, 1865 AVE test, unbalanced factorial design clinical trials fertility studies, 665 2079 generalized population attributable fr = verage Dioequivalence 1Y 94 2811, . 2821, 2843 INTG headbanging algorithm, 2309 iverage squared error Monte ( arlo, 389 HIV infection risk, 264] journal trends, 32 B-test age-specific reference intervals, 2943 longitudinal studies with continuous outcome Dack pain, cost data analysts 3219 1339 back calculation meta-analysis, 3251, 3497 age-specific incidence, 281] missing COvariate vaiues AIDS incubation time uncertainty, 175 partition structures, 2579 HIV & AIDS epidemics reconstruction, 161 quality of life, 32—3 HIV & AIDS surveillance data 297 risk factor assessment, 1523 vack-projyection, HIV incidence rates estimation robust empirical, 975 165 small area disease risks, 2409 back-propagation algorithm, prognostic and diagnos space-time models, 2569 tic classification, 541 space-time variation, 2555 backward elimination, smoking and drinking interac spatial models, 1915, 2279 tions, 1685 spatio-temporally misaligned data, 2265 backwards stepwise selection, prognostic modelling, Bayesian predictive inference, group sequential 1059 designs, 3023 2 SUBJECT INDEX ian random effects models menopause bioequivalence alysis, 12] vee ilso average bi EQUI alence individual bioe I Ot Sel vation Rating (BO X>x guivalence population bioequivalence ioural rating scales Alzheimer Special Issue ike lihood. fertility stu il total deviation agakos formula $4] biomarkers ell’s general test censored measuremen Mollie (BYM) mode longitudinal, 61 trajectories model indDiased estimates birth 29 399 iss mod onditi indall Rating Scale (BDRS Men ory ( centrauiol n Tt vlc | odel non-linear m ' inb itudinal tinuous tientin D 1100 and Bellomo Imn ue li mult el model 267 ds). Eneve lope dia of non-compliance and sample siz¢ B nary responses \zzalini A... Statistical lr ifJ e rence Ba> sed on [ile GEI analysis, 715 Likelihood 1260 mult i-centre data, 1115 Barnett V Stein, A and Feridun Turkman, K binomiz il data, exact sequential tests 305 1 (eds) Statistics for the Environment 4 binomi al regression, Bayesian accelerated failure Statistical Aspe cts of H ealth and the time analysis > 21 Environment 1824 3530 SUBJECT INDEX Bernardo, J. M., Berger, J. O., Dawid, A. P. and and Spatially Correlated Data: Methods Smith, A. F. M. (eds), Bayesian Statistics 6., Applications and Future Directions, 1258 3143 Haberman, S. and Pitacco, E., Actuarial Models Brillinger, D. R., Fernholz, L. T. and for Disability Insurance, 1381} Morgenthaler S. (eds), The Practice of Data Hargrove, J. L.. Dynamic Modeling in the Health Analysis: Essays in Honor of John W. Tukey Sciences, 3142 R84 Hollander, M. and Wolfe, D. A., Nonparametr Cheng, C.-L. & Van Ness, J. W, Statistical Statistical Methods, 1386 Reeression with Measurement Error, 20 Hosmer, D. W. and Lemeshow, S., Applied Chow, S.-C. & Liu, J.-P. (eds), Design and Survival Analysis. Regression Modeling of Time Analysis of Animal Studies in Pharmaceutical to Event Data, 1823 Deve lopment 1953 Hsu, J. C., Multiple Comparisons - Theor Chow, S.-C. and Liu, J.-P., Design and Analysis of Methods, 1951 Clinical Trials, 3021 Jorgensen, B., The Theory of Dispersion Mod Clarke, G. M. and Kempson, R. E., /ntroduction to 1952 the Design and Analysis of Experiments, 882 Kanji, G. K., /00 Statistical Tests. 3018 \., Haggett, P. and Smallman-Raynor, M Klinke, S., Data Stru €s for Computatio ciphering Global Epidemics: Analytical Statistics, 3019 aches to the Disease Records of World Koornwinder, T 1888 19]? 27 15 Treatment of D. R. and Wermuth, N.. Multivariate Krickeberg, K., Petit ¢ De pe ndencies. Models. Analysis and Krzanowski, W. J.. An Introduction to _— Interpretation VModelline. 1380 Cruickshante, S.. Mathematics and Statistics in Lange, K., Mathematic Anaesthesia. 1385 for Genetic Ana Day, S., Dictionary for Clinical Trials, 3144 Lindsey J K Re Draper, N. R. and Smith, H., Applied Regression 402? Analysis 3rd edn, 3136 Neuilly, M., Mode Dryden L. and Mardia, K. V., Statistical Shape Measurement Error 2716 Parkin, D. M.. Whelan B. S. and Dunn, G. (eds), Statistical L. and Young, J of Medical Data. New Developments Five Cont Pereira-Max we S., Dunn, G. and Holford, T. R. (eds Compar ior Methods in Medical Research: The Rao, P.S.R stics of Smoking, 1379 1008 Parkin, D. M. and Pisani, P., Globocan Rothman, K. J. and Gre cer Incidence and Mortality Worldwide Epide miolos’ nd Royall, R Firebaugh, G., Analyzing Repeated Surve 95] Paradi: Gad, S. ¢ Statistics and Experimental Design for Schafer, J. L.. Analysis o ( te Mult Toxicologists pi) Data. |\O006 Gamerman, D., Markov Chain Monte Carlo Schnabel, M., Experter teme in der Med Stochastic Simulation for Bayesian Inference Eine infiihrune mit Beispielen, 1949 883 Sham, P., Statistics in Human Genetics, 1384 Gerstman, B. B., Epidemiology Kept Simple: An Staquet, M. J., Hays, R. D. and Fayers, P. M Introduction to Clas and Modern (eds), Quality of Life Assessment in Clinica Epidemiology, 1005 Trials: Methods and Practice, 1382 Gower, J. C. and Hand, D. J., Biplots, 278 Stuart, A., Ord, K. and Arnold, S., Kendall Greenfield, T. (ed), Research Methods - Guidance Advanced Theory of Statistics. Volume 2A for Postgraduates, 3020 Classical Inference and the Linear Model, 3139 Gregoire, T. G., Brillinger, D. R., Diggle, P. J Thompson, M. E., Theory of Sample Surveys, 182 Ss Russek-Cohen, E., Warren, W. G. and Vermunt, J. K., Log-linear Models for Event Wolfinger, R. D. (eds), Modeling Longitudinal Histories, 1263 SUBJECT INDEX Waller, N. G. and Meehl, P. E., Multivariate monotonic non-linear model, 2053 Taxometric Procedures, 2713 prevention trials design, 1983 Winkelmann, R., Econometric Anal s of Count prognostic factors with censored data, 601 Data 2nd ed., 276 subpopulation treatment effect pattern plot, 2595 Zelterman, D., Models for Discrete Data, 1829 tree stability diagnostics, 475 bootstrap Brier score, tumour Staging and grading systems AIDS incubation time uncertainty, 175 1997 approximate Bayesian, | British Medical Journal, 3149 attributable risk confidence intervals, 1089 bronchitis, space-time models, 2569 bioequivalence, 2769, 2811 Buschke Selective Reminding test, 1555 Canadian Cancer Incidence Atlas, 2437 cluster randomized trial, 2675 calibration, prognostic survival models, 3401 conditional autoregressive models, 2421 Canadian Cancer Incidence Atlas, 2437 confidence intervals, 313, 11 Canadian Study of Health and Aging, 1685 cost data analysis, 3219 cancel cost-effectiveness analysis, 2989 attributable risk confidence intervals, 1089 diagnostic markers/repeated measurements com Dreast parison, 511 cluster randomized trial, 2675 generalized linear model predictive po continuation ratio random effects model, 3377 ndividual bioequivalence, 2741, 27 2 cubic smoothing spline models, 1191 nter i | censored data survival function, 2611 cumulative cause-specific mortality, 1729 latent class mixed model, 1303 diagnostic markers/repeated measurements com meta-analysis, 3417 parison, 511 multi-state models, 587, 3465 false-positive cumulative risk, 1865 percentile method, 1141 generalised synthesis of evidence, 3359 ndividual bioequivalenc: interval censored data, |, 2611 profile similarity, 2855 interval censored data hazard function, 405 prognostic models, 14] linear mixed effects models, 2251 ROC curves, 493 monotonic non-linear model, 2053 screening tests verification bias, 1697 prevention trials design, 1983 time since seroconversion estimation, 1753 prognostic factors with censored data, 601 time to onset of response, 2169 subpopulation treatment effect pattern plot, 2595 tree stability diagnostics, 475 tree stability diagnostics, 475 tumour staging and grading systems, 1997 Canadian Cancer Incidence Atlas, 2437 bootstrap-r, 1141 conditional models in bivariate survival, 563 st data analysis, 3219 group sequential longitudinal trials, 205 individual bioequivalence, 274 head, anaemia effects, 1237 Box-Tidwell model, monotonic non-linear model incidence prediction, 1741 053 joinpoint regression, 335 Box-Tidwell power curves, continuous covariates larynx, disease mapping, 2493 modelling effect, 1831 leukaemia, cluster probability due to chance, 2195 Bradford Hill Memorial Lecture lip breast Cancel Bayesian disease mapping cluster randomized trial, 26 7S disease mapping, 957 continuation ratio random effects model posterior predictive model checks, 2377 cubic smoothing spline models, 1191 spatial model selection, 1915 cumulative cause-specific mortality, 1729 lung diagnostic markers repeated measurements com messy longitudinal data, 2657 parison, 511 proportional hazards model, 3309 false-positive cumulative risk, 1865 risk of smoking, 2185 generalised synthesis of evidence 2 space-time mixture modelling interval censored data, |, 261 1 space-time variation, 2555 interval censored data hazard function, 405 spatio-temporal interaction, 2015 linear mixed effects models, 2251 triple-goal estimates 2295 SUBJECT INDEX multiple treatment courses evaluation, 1011 epidemiology, 2521 neck, anaemia effects 1237 space-time mixture modelling, 2333 non-Hodgkin's lymphoma, prognostic survival cholesterol models, 3401 meta-analysis, 3497 ovarian, prognostic factors sample size, 441 randomized clinical trials treatment effects, 1849 prevention trials design, 1983 chronic granulotomous disease (CGD), proportional prognostic and diagnostic classification, 541 hazards model, 3309 prognostic variable categorization, 113 chronic obstructive pulmonary disease (COPD), 2521 prostate chunking, smoking and drinking interactions, 1685 cumulative cause-specific mortality, 1729 circulatory disease, multivariate spatial models, 2469 inference on a collapsed margin, 2243 cirrhosis, meta-analysis, 3251 latent class mixed model, 1303 classical weighted least squares (CWLS), 2919 longitudinal biomarkers, 617 Clinic for Alzheimer Disease and Related Disorders multiple treatment courses, 101 | 1685 random effect selection model, 3237 Clinical Dementia Rating (CDR), Alzheimer’s rectal, sequential analysis, 3449 disease, 1393, 1433 ROC curves regional confidence bands, 493 closed multiple testing procedure, 353 tumour response and survival, 837 cluster evaluation permutation procedure, 1363 tumour staging and grading systems, 1997 cluster modelling, RJIMCMC methods, 2361 capture-recapture methods, vaccine efficacy cluster probability, due to chance, 2195 estimation, 827 cluster process model, rheumatoid vasculitis, 3433 carcinogenesis study, multiple comparisons, 353 cluster randomized trials caregivers, group sequential longitudinal trials, 205 journal trends, 3275 Carstairs index, disease mapping, 2493 multi-level model, 2675 CART cluster sampling, risk ratio, 2933 prognostic models, 453 clustered failure time data, permutation tests, 2963 tree stability diagnostics, 475 clustered survival data,proportional hazards model, 3309 cartograms, disease mapping, 2203 clustering case deletion diagnostics, accelerated failure time spatial disease clustering, 191 analysis, 221 tests comparison, 1363 case-control studies cocaine, stroke risk, 99 attributable risk confidence intervals, 1089 Cochran-Armitage test, power comparisons, 3037 matching, 35 Cochran-Mantel-Haenszel statistic, messy pair-matched, 923 longitudinal data, 2657 paired organs, 525 Cochrane Pregnancy and Childbirth Database, 1707 sequential analysis, 3449 coefficient of determination, dichotomous outcomes, smoking and lung cancer, 2185 271 categorical repeated measurements, conditional cognitive assessment measures, differential item models, 801 functioning, 1651 censored biomarker measurements, analysis and cognitive change measurement, Alzheimer’s disease design, 3171 1421 censored data, prognostic factors, 601 cognitive tests, Alzheimer’s disease, 1393, 141] census regression coefficients, community-based Cohen-Sackrowitz exact test, power comparisons studies, 1469 4004 CERAD see Consortium to Establish a Registry for Cohen's kappa, interval estimation, 723 Alzheimer’s Disease cohort studies change point model decline pattern modelling, 1593 Alzheimer’s disease, 1555 Monte Carlo, 2933 longitudinal biomarkers, 617 time since seroconversion estimation, 1753 chi-square, malaria risk factors, 1931 collapsed margin, disease mapping, 2243 chickenpox, SEIR model, 1207 colorectal hepatic metastases, random effect selection childhood infectious diseases, survival analysis, 13 model, 3237 chloropleth maps combination drug trials, unbalanced factorial ce , _— disease mapping, 2203 clinical trials, 2079